RTW Investments added 11,809,392 shares of Tango Therapeutics last quarter, an estimated $164.37 million purchase based on average quarter prices. The filing signals meaningful institutional accumulation in a healthcare/biotech name, but the article provides no operational update or catalyst beyond the position increase.
RTW Investments added 11,809,392 shares of Tango Therapeutics last quarter, an estimated $164.37 million purchase based on average quarter prices. The filing signals meaningful institutional accumulation in a healthcare/biotech name, but the article provides no operational update or catalyst beyond the position increase.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.15
Ticker Sentiment
